Striatopallidal Changes in Early Parkinson’s Disease

R. Macias, L. Alvarez, M. Rodriguez, Jerrold L Vitek, M. R. DeLong, J. Guridi, J. A. Obeso, M. C. Rodriguez-Oroz, Pathophysiologic basis of surgery for Parkinson's disease Neurology. ,vol. 55, ,(2000)

Mark P. Mattson, Apoptosis in neurodegenerative disorders. Nature Reviews Molecular Cell Biology. ,vol. 1, pp. 120- 129 ,(2000) , 10.1038/35040009

J.Timothy Greenamyre, Gillian MacKenzie, Tsung-I Peng, Stacy E. Stephans, Mitochondrial Dysfunction in Parkinson’s Disease Biochemical Society Symposia. ,vol. 66, pp. 85- 97 ,(1999) , 10.1042/BSS0660085

Todd B. Sherer, Ranjita Betarbet, Amy K. Stout, Serena Lund, Melisa Baptista, Alexander V. Panov, Mark R. Cookson, J. Timothy Greenamyre, An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage The Journal of Neuroscience. ,vol. 22, pp. 7006- 7015 ,(2002) , 10.1523/JNEUROSCI.22-16-07006.2002

Nadine A. Tatton, Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's Disease Experimental Neurology. ,vol. 166, pp. 29- 43 ,(2000) , 10.1006/EXNR.2000.7489

J. Langston, P Ballard, J. Tetrud, I Irwin, Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science. ,vol. 219, pp. 979- 980 ,(1983) , 10.1126/SCIENCE.6823561

Laura K. Nisenbaum, William R. Crowley, S.T. Kitai, Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression. Molecular Brain Research. ,vol. 37, pp. 209- 216 ,(1996) , 10.1016/0169-328X(95)00317-L

I.J Mitchell, A.J Cooper, M.R Griffiths, The selective vulnerability of striatopallidal neurons Progress in Neurobiology. ,vol. 59, pp. 691- 719 ,(1999) , 10.1016/S0301-0082(99)00019-2

C. Gerfen, T. Engber, L. Mahan, Z Susel, T. Chase, F. Monsma, D. Sibley, D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons Science. ,vol. 250, pp. 1429- 1432 ,(1990) , 10.1126/SCIENCE.2147780

H. Mochizuki, H. Hayakawa, M. Migita, M. Shibata, R. Tanaka, A. Suzuki, Y. Shimo-Nakanishi, T. Urabe, M. Yamada, K. Tamayose, T. Shimada, M. Miura, Y. Mizuno, An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 10918- 10923 ,(2001) , 10.1073/PNAS.191107398